Join
Live feed
·
PRReleasevia Quantisnow
Seagen Inc. logo

Seagen to Host Conference Call and Webcast Discussion on September 21, 2021 to Discuss TIVDAK™ (tisotumab vedotin-tftv) Approval

ByQuantisnow·Wall Street's wire, on your screen.
SGEN· Seagen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGEN (Seagen Inc.) and more on Quantisnow.